Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Operating Income (2020 - 2022)

Sonoma Pharmaceuticals (SNOA) has 3 years of Operating Income data on record, last reported at -$680000.0 in Q4 2012.

  • For Q4 2012, Operating Income rose 71.11% year-over-year to -$680000.0; the TTM value through Dec 2012 reached -$3.5 million, up 45.88%, while the annual FY2012 figure was -$6.5 million, 13.83% up from the prior year.
  • Operating Income reached -$680000.0 in Q4 2012 per SNOA's latest filing, up from -$817000.0 in the prior quarter.
  • Across five years, Operating Income topped out at -$495000.0 in Q2 2012 and bottomed at -$2.4 million in Q2 2010.
  • Average Operating Income over 3 years is -$1.5 million, with a median of -$1.5 million recorded in 2012.
  • The widest YoY moves for Operating Income: up 75.47% in 2012, down 29.68% in 2012.
  • A 3-year view of Operating Income shows it stood at -$2.1 million in 2010, then fell by 13.28% to -$2.4 million in 2011, then soared by 71.11% to -$680000.0 in 2012.
  • Per Business Quant database, its latest 3 readings for Operating Income were -$680000.0 in Q4 2012, -$817000.0 in Q3 2012, and -$495000.0 in Q2 2012.